Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ment, L. R.
Right arrow Articles by Duncan, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ment, L. R.
Right arrow Articles by Duncan, C. C.
NEUROLOGY 1983;33:179
© 1983 American Academy of Neurology

Beagle puppy model of intraventricular hemorrhage

Randomized indornethacin prevention trial

Laura R. Ment, MD, William B. Stewart, PhD, David T. Scott, PhD and Charles C. Duncan, MD

Yale University School of Medicine, New Haven, CT.

The newborn beagle puppy has been demonstrated to provide a good model for neonatal intraventricular hemorrhage (IVH). By randomized computerized design, indomethacin, a known inhibitor of prostaglandin synthetase, was administered to newborn beagle puppies, all of which underwent the experimental model of hemorrhagic hypotension followed by volume reexpansion for the production of IVH, to determine whether indomethacin can prevent intraventricular hemorrhage in this model. Nine percent of all pups receiving indomethacin experienced intraventricular hemorrhage, compared with 80% of animals who received the saline vehicle. In addition, significant alterations in the blood pressure responses to the hemorrhagic hypotension/volume reexpansion insult were noted in this group when compared with control animals.

Address correspondence and reprint requests to Dr. Ment, Department of Pediatrics, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510.

This work was supported by the Charles H. Hood Foundation, Boston, and by the Ohse Fund, Yale University School of Medicine, New Haven, CT.

Accepted for publication June 7, 1982




This article has been cited by other articles:


Home page
 J Child NeurolHome page
J. Balasubramaniam and M. R. Del Bigio
Topical Review: Animal Models of Germinal Matrix Hemorrhage
J Child Neurol, May 1, 2006; 21(5): 365 - 371.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
R. J. Couser, R. E. Hoekstra, T. B. Ferrara, G. B. Wright, A. K. Cabalka, and J. E. Connett
Neurodevelopmental Follow-up at 36 Months' Corrected Age of Preterm Infants Treated With Prophylactic Indomethacin
Arch Pediatr Adolesc Med, June 1, 2000; 154(6): 598 - 602.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
V. S. Miller
Topical Review Article: Pharmacologic Management of Neonatal Cerebral Ischemia and Hemorrhage: Old and New Directions
J Child Neurol, January 1, 1993; 8(1): 7 - 18.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
K. C.K. Kuban, A. Leviton, M. Pagano, T. Fenton, R. Strassfeld, and M. Wolff
Maternal Toxemia Is Associated With Reduced Incidence of Germinal Matrix Hemorrhage in Premature Babies
J Child Neurol, January 1, 1992; 7(1): 70 - 76.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by AAN Enterprises, Inc.